Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis

Keyphrases

• Multiple Sclerosis 100%
• Antibody Response 100%
• Myelin Oligodendrocyte Glycoprotein 100%
• Pathogenic Antibodies 100%
• Multiple Sclerosis Treatment 40%
• Autoantibodies 30%
• Antibody Titer 20%
• Demyelination 20%
• Chronic Inflammatory Diseases 10%
• High Prevalence 10%
• Pathogenicity 10%
• Cause of Disease 10%
• Nervous System Diseases 10%
• High Sensitivity 10%
• High Affinity 10%
• Conformational Epitope 10%
• IgM Antibody 10%
• Autoimmune Response 10%
• Experimental Autoimmune Encephalomyelitis 10%
• Extracellular Domain 10%
• Self-antigens 10%
• Progressive multiple Sclerosis 10%
• White Matter 10%
• Myelin 10%
• Rat Brain 10%
• Autoimmune Encephalitis 10%
• Axonal Loss 10%
• Myelin Sheath 10%
• Myelin Antigens 10%
• Axonal Damage 10%
• Myelin Oligodendrocyte Glycoprotein Antibody 10%
• Potential Diseases 10%

Immunology and Microbiology

• Multiple Sclerosis 100%
• Antibody Response 100%
• Myelin Oligodendrocyte Glycoprotein 100%
• Autoantibodies 27%
• Myelin 18%
• Antibody Titer 18%
• Autoimmunity 9%
• Inflammatory Disorder 9%
• Primary Progressive Multiple Sclerosis 9%
• Central Nervous System 9%
• White Matter 9%
• Prevalence 9%
• Myelin Sheath 9%
• Immunoglobulin M Antibody 9%
• Experimental Autoimmune Encephalomyelitis 9%
• Target Cell 9%
• Conformational Epitope 9%
• Allergic Encephalomyelitis 9%
• Pathogenicity 9%